港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

高瓴概念

536.305

-8.338-1.53%

漲家數：9

跌家數：41

平家數：5

市盈率：- -

高：548.851

開：544.657

低：534.195

收：544.643

資料載入中...

舒泰神：取得關於BDB-001注射液的I/II期臨牀研究總結報告

君實生物跌1.69%，成交額7.82億元，近3日主力淨流入-5811.00萬

嘉和生物-B盤中異動急速下跌5.26%

李氏大藥廠抗PD-L1單抗新適應症獲批，治療小細胞肺癌

生物制品圈

中升控股盤中異動臨近收盤急速下挫5.16%

港股異動 | 物管股集體下跌大行稱物管行業中期盈利增長或放緩預計估值修復期已結束

邁威生物(688062.SH)注射用7MW4911臨牀試驗申請獲受理

研報掘金丨開源證券：恩華藥業業績驅動因素明確，維持“買入”評級

A股異動丨腦機接口概念拉昇，國家醫保局支持腦機接口等進入臨牀並收費

豪擲200億！劉強東欲拿下歐洲最大電子零售商Ceconomy，京東開始登陸歐洲

中国江西网

港股異動 | 啤酒股午後跌幅擴大啤酒6月產量同比下降機構稱政策有望修復旺季表現預期

智通财经网

大行評級｜里昂：微降中海物業目標價至6.1港元維持“跑贏大市”評級

恆瑞醫藥股價暴漲！創新藥BD“黃金時代”真的來了？

中国食品药品网

海吉亞醫療盤中異動下午盤大幅下跌5.01%

研報掘金丨華西證券：維持藥明康德“買入”評級，整體業績增長中樞提升

翰森製藥盤中異動下午盤急速下挫3.02%報35.300港元

呷哺呷哺盤中異動股價大跌6.10%報0.770港元

心通醫療-B盤中異動下午盤大幅跳水5.44%報1.390港元

德琪醫藥-B盤中異動下午盤大幅跳水5.07%報5.430港元

明源雲盤中異動大幅上漲5.00%

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK1583/news?page=9"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1583","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","market":"HK","secType":"PLATE","nameCN":"高瓴概念","latestPrice":536.3049,"timestamp":1754035689688,"preClose":544.6429,"halted":0,"volume":1273915179,"delay":0,"changeRate":-0.015309,"floatShares":0,"shares":0,"eps":0,"marketStatus":"休市中","change":-8.338013,"latestTime":"08-01 16:00:00","open":544.6572,"high":548.851,"low":534.19507,"amount":21412358748.8,"amplitude":0.026909,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1754271000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1754011800000,1754020800000],[1754024400000,1754035200000]],"pbRate":2.560761,"peRate":23.337834,"turnoverRate":0.009141,"increases":6,"decrements":43,"flats":4,"marketCap":3097820304512,"floatMarketCap":2380639946624},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","high":548.851,"amplitude":0.026909,"preClose":544.6429,"low":534.19507,"pbRate":"2.560761","latestPrice":536.3049,"volume":1273915179,"delay":0,"open":544.6572,"prevYearClose":446.93042,"prevWeekClose":548.862,"prevMonthClose":544.643,"prevQuarterClose":500.645,"fiveDayClose":548.862,"twentyDayClose":502.828,"sixtyDayClose":482.232,"secType":"PLATE","market":"HK","turnoverRate":0.009141,"peRate":23.337834,"marketCap":3097820304512,"floatMarketCap":2380639946624,"timestamp":1754035689688,"nameCN":"高瓴概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1583\",,,,undefined,":{"bkCode":"BK1583","up":9,"down":41,"flat":5},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1583\",pageSize:20,pageCount:9,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2555922002","title":"舒泰神：取得關於BDB-001注射液的I/II期臨牀研究總結報告","url":"https://stock-news.laohu8.com/highlight/detail?id=2555922002","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555922002?lang=zh_tw&edition=fundamental","pubTime":"2025-07-31 16:08","pubTimestamp":1753949306,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4585","161726","BK4153","BK0046","AA","399441","BK0028","03347","BK1141","BK1583","BK0239","BK4588","BK1576","300204"],"gpt_icon":0},{"id":"2555867007","title":"君實生物跌1.69%，成交額7.82億元，近3日主力淨流入-5811.00萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2555867007","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555867007?lang=zh_tw&edition=fundamental","pubTime":"2025-07-31 16:06","pubTimestamp":1753949207,"startTime":"0","endTime":"0","summary":"来源：新浪证券-红岸工作室7月31日，君实生物跌1.69%，成交额7.82亿元，换手率2.60%，总市值394.86亿元。截至3月31日，君实生物股东户数2.94万，较上期增加0.24%；人均流通股25987股，较上期减少0.23%。2025年1月-3月，君实生物实现营业收入5.01亿元，同比增长31.46%；归母净利润-2.35亿元，同比增长17.01%。香港中央结算有限公司位居第九大流通股东，持股1499.56万股，相比上期增加152.78万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073116135094c5ae4b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073116135094c5ae4b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688180","01877","BK1161","BK1515","BK1583"],"gpt_icon":0},{"id":"2555002687","title":"嘉和生物-B盤中異動 急速下跌5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555002687","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555002687?lang=zh_tw&edition=fundamental","pubTime":"2025-07-31 15:44","pubTimestamp":1753947898,"startTime":"0","endTime":"0","summary":"2025年07月31日临近收盘15时44分，嘉和生物-B股票出现异动，股价快速下挫5.26%。截至发稿，该股报2.700港元/股，成交量137.8万股，换手率0.26%，振幅5.61%。嘉和生物-B股票所在的生物技术行业中，整体跌幅为0.94%。其相关个股中，创胜集团-B、科伦博泰生物-B、盛禾生物-B涨幅较大，振幅较大的相关个股有奥星生命科技、中国抗体-B、创胜集团-B，振幅分别为22.50%、19.32%、14.16%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731154458a6cb1b85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731154458a6cb1b85&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06998","BK1574","BK1583"],"gpt_icon":0},{"id":"2555007863","title":"李氏大藥廠抗PD-L1單抗新適應症獲批，治療小細胞肺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=2555007863","media":"生物制品圈","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555007863?lang=zh_tw&edition=fundamental","pubTime":"2025-07-31 15:43","pubTimestamp":1753947800,"startTime":"0","endTime":"0","summary":"7月30日，中国国家药监局官网最新公示，李氏大药厂旗下子公司兆科肿瘤申报的抗PD-L1单克隆抗体索卡佐利单抗新适应症上市申请已获得批准。根据李氏大药厂公开资料可知，该药本次获批的适应症为联合化疗一线治疗广泛期小细胞肺癌。本次是索卡佐利单抗在中国获批的又一项适应症。索卡佐利单抗或安慰剂联合卡铂和依托泊苷一线治疗广泛期小细胞肺癌的III期临床研究成果发表国际知名学术期刊！","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731155152a6cb1fab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731155152a6cb1fab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1583","00950","06622","BK1191","BK1574"],"gpt_icon":0},{"id":"2555007706","title":"中升控股盤中異動 臨近收盤急速下挫5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555007706","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555007706?lang=zh_tw&edition=fundamental","pubTime":"2025-07-31 15:43","pubTimestamp":1753947784,"startTime":"0","endTime":"0","summary":"2025年07月31日临近收盘15时43分，中升控股股票出现异动，股价大幅下挫5.16%。截至发稿，该股报13.220港元/股，成交量925.948万股，换手率0.39%，振幅5.45%。中升控股股票所在的汽车零售商行业中，整体跌幅为0.33%。其相关个股中，和谐汽车、陈唱国际、中建富通涨幅较大，振幅较大的相关个股有和谐汽车、陈唱国际、美东汽车，振幅分别为32.67%、10.45%、5.38%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073115430494c59be2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073115430494c59be2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00881","BK1583","LU1102505762.USD","LU0173614495.USD","BK1520","LU0287142896.SGD","BK1589","BK1239"],"gpt_icon":0},{"id":"2555004408","title":"港股異動 | 物管股集體下跌 大行稱物管行業中期盈利增長或放緩 預計估值修復期已結束","url":"https://stock-news.laohu8.com/highlight/detail?id=2555004408","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555004408?lang=zh_tw&edition=fundamental","pubTime":"2025-07-31 15:41","pubTimestamp":1753947717,"startTime":"0","endTime":"0","summary":"消息面上，瑞银发布研报称，中国物业管理商2025年上半年财报预期将持续放缓，预计平均盈利同比增幅将放缓至13%，低于2024年上半年的17%及2024年全年的14%增长，对比市场预期为15%，主要受到住宅市场放缓所拖累，令在管面积增长减慢、物业费收缴率下降、开发商增值服务减少及社区增值服务毛利率受压。美银证券则表示，中国物管股年初至今股价累计上涨逾20%，预期估值修复期已结束。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1324102.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1589","BK1258","02602","06098","03319","01516","BK1585","BK1583","BK1542","BK1229"],"gpt_icon":0},{"id":"2555004534","title":"邁威生物(688062.SH)注射用7MW4911臨牀試驗申請獲受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2555004534","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555004534?lang=zh_tw&edition=fundamental","pubTime":"2025-07-31 15:36","pubTimestamp":1753947393,"startTime":"0","endTime":"0","summary":"智通财经APP讯，迈威生物(688062.SH)公告，公司收到国家药品监督管理局(NMPA)签发的《受理通知书》，注射用7MW4911的临床试验申请已获正式受理;此外，公司收到美国食品药品监督管理局(FDA)出具的 IND Acknowledgement Letter，确认已收到公司就注射用7MW4911递交的IND申请。公告显示，7MW4911是基于公司自主知识产权的IDDC™抗体偶联技术平台开发的靶向钙黏蛋白17(CDH17)的创新抗体偶联药物(ADC)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1324098.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03347","BK1141","BK1583","BK0239","688062","BK1576"],"gpt_icon":0},{"id":"2555043770","title":"研報掘金丨開源證券：恩華藥業業績驅動因素明確，維持“買入”評級","url":"https://stock-news.laohu8.com/highlight/detail?id=2555043770","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555043770?lang=zh_tw&edition=fundamental","pubTime":"2025-07-31 15:34","pubTimestamp":1753947259,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["161027","SAVA","159992","002262","BK0070","BK0239","BK1574","BK1583","BK4547","BK4585","06978","BK4588","03347","BK1161","BK0188","BK4007","BK1141","BK1576"],"gpt_icon":0},{"id":"2555009999","title":"A股異動丨腦機接口概念拉昇，國家醫保局支持腦機接口等進入臨牀並收費","url":"https://stock-news.laohu8.com/highlight/detail?id=2555009999","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555009999?lang=zh_tw&edition=fundamental","pubTime":"2025-07-31 14:57","pubTimestamp":1753945039,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0214","BK0231","301293","BK0096","300753","603610","BK0114","BK1574","BK1222","301330","159873","BK0236","BK0196","BK0077","BK1583","BK0095","159883","09996","BK0251","BK0260","09997","BK0183","002173","BK0154","002195","BK1100","159891"],"gpt_icon":0},{"id":"2555009035","title":"豪擲200億！劉強東欲拿下歐洲最大電子零售商Ceconomy，京東開始登陸歐洲","url":"https://stock-news.laohu8.com/highlight/detail?id=2555009035","media":"中国江西网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555009035?lang=zh_tw&edition=fundamental","pubTime":"2025-07-31 14:50","pubTimestamp":1753944642,"startTime":"0","endTime":"0","summary":"7月24日，欧洲最大电子产品零售商Ceconomy发布此声明。据悉，刘强东考虑以每股4.6欧元的价格入股，相较Ceconomy 23日的收盘价，溢价率高达22.7%。京东自知健康领域还看不到突破的机会，便索性加码自己更擅长的电子消费领域，知情人士透露，刘强东要想拿下Ceconomy，得和多家传统欧洲豪门打交道。尽管Ceconomy声明指出，和京东尚未签署任何协议，但行内人士都认为已板上钉钉。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731145248a46ced00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731145248a46ced00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1044874839.SGD","LU0791591158.USD","LU1251922891.USD","LU0359201612.USD","LU0572944931.SGD","LU0588545730.USD","06618","LU0359202008.SGD","LU0228367735.SGD","LU0164880469.USD","BK1615","89618","LU0048580855.USD","LU0417516902.SGD","LU0456846285.SGD","LU1770036033.HKD","BK1610","LU1808992512.USD","BK1502","LU0149721374.USD","BK1583","LU0128522157.USD","LU0348735423.USD","SG9999001226.SGD","LU0417516738.SGD","LU0314109678.HKD","BK1591","BK1249","LU0865486749.SGD","LU1282649810.SGD","LU0320764599.SGD","LU0348805143.USD","LU0456827905.SGD","LU1770034418.SGD","LU2242644610.SGD","LU0384037296.USD","09618","LU0163747925.USD","BK1588","JD","86618","LU1023057109.AUD","LU1366334578.USD","LU0871576103.HKD","LU1282651121.HKD","BK1571","LU0231483743.USD","LU0791590937.USD","LU0588546209.SGD","LU0345776255.USD"],"gpt_icon":1},{"id":"2555009104","title":"港股異動 | 啤酒股午後跌幅擴大 啤酒6月產量同比下降 機構稱政策有望修復旺季表現預期","url":"https://stock-news.laohu8.com/highlight/detail?id=2555009104","media":"智通财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555009104?lang=zh_tw&edition=fundamental","pubTime":"2025-07-31 14:45","pubTimestamp":1753944332,"startTime":"0","endTime":"0","summary":"消息面上，2025年6月，我国规模以上企业啤酒产量412.0万千升，同比下降0.2%。1-6月，中国规模以上企业累计啤酒产量1904.4万千升，同比下降0.3%。东莞证券指出，禁酒令发布后，短期市场情绪放大，啤酒亦受到一定扰动。纠偏后，近期市场情绪有所回暖。此前啤酒行业受外部消费环境+禁酒令等影响，销量&销量预期承压。此次消费刺激政策有望修复对啤酒板块旺季表现的预期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1324071.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1180","IE00BGV7N243.SGD","LU0543330483.HKD","BK1610","BK1521","IE0031814852.USD","LU0128522157.USD","LU0320764755.SGD","BK1510","LU1328615791.USD","SG9999000459.SGD","LU1769817096.USD","01876","IE00B031HY20.USD","LU0762540952.USD","SG9999006514.SGD","CRHKY","00291","LU0197773160.USD","80291","BK1604","LU0572944931.SGD","LU0359201612.USD","LU0630378692.HKD","LU1794554557.SGD","LU0630378429.USD","BK1589","IE00BPRC5H50.USD","LU1720050803.USD","LU0762542818.HKD","IE00B5MMRT66.SGD","LU1023057109.AUD","BK1578","IE0008369823.USD","IE00B0169L03.USD","IE00B29SXG58.USD","LU0359202008.SGD","LU0029875118.USD","00168","LU0197773673.USD","LU0328353924.USD","IE00B543WZ88.USD","SG9999001903.USD","LU1769817179.HKD","LU0762541174.USD","LU0672654166.SGD","LU0327786744.USD","BK1583","LU0831093199.SGD","IE0008368742.USD"],"gpt_icon":0},{"id":"2555006260","title":"大行評級｜里昂：微降中海物業目標價至6.1港元 維持“跑贏大市”評級","url":"https://stock-news.laohu8.com/highlight/detail?id=2555006260","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555006260?lang=zh_tw&edition=fundamental","pubTime":"2025-07-31 14:37","pubTimestamp":1753943841,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1542","BK1229","BK1148","06958","BK1240","BK1583","09979","09983","06968","02669","BK1258","01971","BK1097"],"gpt_icon":0},{"id":"2555098280","title":"恆瑞醫藥股價暴漲！創新藥BD“黃金時代”真的來了？","url":"https://stock-news.laohu8.com/highlight/detail?id=2555098280","media":"中国食品药品网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555098280?lang=zh_tw&edition=fundamental","pubTime":"2025-07-31 14:33","pubTimestamp":1753943580,"startTime":"0","endTime":"0","summary":"根据协议，恒瑞医药将获得5亿美元首付款，潜在交易总额最高可达120亿美元。在恒瑞医药亮眼表现下，医药ETF当日上涨2.24%，亦创下年内新高。“中国创新药海外BD交易的黄金时代已经到来。”“今年以来，创新药BD交易过亿美元大单频现。”岳云认为，这一交易刷新了当时中国创新药单笔授权交易纪录，也刷新中国创新药BD交易最高首付款的纪录。买方卖方各取所需业内普遍认为，创新药BD交易如火如荼，是买方和卖方各取所需。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731143654a6cafe42&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731143654a6cafe42&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06978","BK1583","BK1191","BK1593","600276","01530","688331","01276","BK1574","BK1161","09995"],"gpt_icon":1},{"id":"2555825009","title":"海吉亞醫療盤中異動 下午盤大幅下跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555825009","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555825009?lang=zh_tw&edition=fundamental","pubTime":"2025-07-31 14:09","pubTimestamp":1753942145,"startTime":"0","endTime":"0","summary":"2025年07月31日下午盘14时09分，海吉亚医疗股票出现波动，股价快速跳水5.01%。截至发稿，该股报17.080港元/股，成交量772.72万股，换手率1.25%，振幅5.34%。海吉亚医疗股票所在的医疗及医学美容服务行业中，整体涨幅为0.03%。其相关个股中，瑞丽医美、现代健康科技、中国再生医学涨幅较大，振幅较大的相关个股有中国再生医学、瑞丽医美、现代健康科技，振幅分别为28.09%、22.88%、11.24%。海吉亚医疗公司简介：海吉亚医疗控股有限公司是一家主要从事医疗服务的公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731140905972962ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731140905972962ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","LU2488822045.USD","LU0737861772.HKD","LU0329678337.USD","LU0329678170.USD","06078","BK1209"],"gpt_icon":0},{"id":"2555196003","title":"研報掘金丨華西證券：維持藥明康德“買入”評級，整體業績增長中樞提升","url":"https://stock-news.laohu8.com/highlight/detail?id=2555196003","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555196003?lang=zh_tw&edition=fundamental","pubTime":"2025-07-31 13:42","pubTimestamp":1753940577,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["002926","LU1997244956.HKD","LU1969619763.USD","LU0052750758.USD","02359","LU1934453819.USD","BK0276","LU2045819591.USD","LU0320764599.SGD","LU2242644610.SGD","LU1997245177.USD","LU2495084118.USD","603259","BK0216","BK1141","LU1979443071.USD","LU2125910500.SGD","LU1046422090.SGD","LU0708995583.HKD","LU2488822045.USD","BK1583","LU0456842615.SGD","LU1997245094.SGD","LU2328871848.SGD","BK1576"],"gpt_icon":0},{"id":"2555000568","title":"翰森製藥盤中異動 下午盤急速下挫3.02%報35.300港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555000568","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555000568?lang=zh_tw&edition=fundamental","pubTime":"2025-07-31 13:40","pubTimestamp":1753940421,"startTime":"0","endTime":"0","summary":"2025年07月31日下午盘13时40分，翰森制药股票出现波动，股价快速下跌3.02%。截至发稿，该股报35.300港元/股，成交量536.221万股，换手率0.09%，振幅4.67%。资金方面，该股资金流入1.11844亿港元，流出6558.63万港元。翰森制药股票所在的药品行业中，整体跌幅为0.21%。其相关个股中，李氏大药厂、泰凌医药、中国同辐涨幅较大，振幅较大的相关个股有泰凌医药、李氏大药厂、中国同辐，振幅分别为26.32%、23.08%、9.38%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073113402194c5692f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073113402194c5692f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1589","03692","BK1583"],"gpt_icon":0},{"id":"2555039210","title":"呷哺呷哺盤中異動 股價大跌6.10%報0.770港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555039210","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555039210?lang=zh_tw&edition=fundamental","pubTime":"2025-07-31 13:25","pubTimestamp":1753939523,"startTime":"0","endTime":"0","summary":"2025年07月31日下午盘13时25分，呷哺呷哺股票出现异动，股价快速下挫6.10%。截至发稿，该股报0.770港元/股，成交量78.55万股，换手率0.07%，振幅2.44%。资金方面，该股资金流入6.571万港元，流出51.4295万港元。呷哺呷哺股票所在的餐饮行业中，整体跌幅为0.39%。其相关个股中，新爱德集团、今米房集团、百福控股涨幅较大，振幅较大的相关个股有唐宫中国、CLASSIFIED GP、MS CONCEPT，振幅分别为7.18%、6.86%、5.88%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731132523a6cae509&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731132523a6cae509&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00520","BK1604","BK1233","BK1583"],"gpt_icon":0},{"id":"2555003189","title":"心通醫療-B盤中異動 下午盤大幅跳水5.44%報1.390港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555003189","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555003189?lang=zh_tw&edition=fundamental","pubTime":"2025-07-31 13:20","pubTimestamp":1753939227,"startTime":"0","endTime":"0","summary":"2025年07月31日下午盘13时20分，心通医疗-B股票出现波动，股价快速跳水5.44%。截至发稿，该股报1.390港元/股，成交量1348.2万股，换手率0.56%，振幅6.80%。资金方面，该股资金流入618.034万港元，流出1162.87万港元。心通医疗-B股票所在的医疗设备及用品行业中，整体跌幅为0.11%。其相关个股中，中国卫生集团、华检医疗、巨星医疗控股涨幅较大，振幅较大的相关个股有中国卫生集团、华检医疗、润迈德-B，振幅分别为61.82%、16.24%、11.90%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731132027a46ccab3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731132027a46ccab3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1100","02160","BK1583"],"gpt_icon":0},{"id":"2555008246","title":"德琪醫藥-B盤中異動 下午盤大幅跳水5.07%報5.430港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555008246","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555008246?lang=zh_tw&edition=fundamental","pubTime":"2025-07-31 13:11","pubTimestamp":1753938664,"startTime":"0","endTime":"0","summary":"2025年07月31日下午盘13时11分，德琪医药-B股票出现异动，股价急速下挫5.07%。截至发稿，该股报5.430港元/股，成交量382.35万股，换手率0.56%，振幅4.90%。德琪医药-B股票所在的药品行业中，整体涨幅为0.29%。其相关个股中，李氏大药厂、泰凌医药、中国同辐涨幅较大，振幅较大的相关个股有泰凌医药、李氏大药厂、中国同辐，振幅分别为26.32%、23.08%、9.38%。该公司主要在亚太地区开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073113110594c55d64&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073113110594c55d64&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","06996","BK1191","BK1583"],"gpt_icon":0},{"id":"2555008292","title":"明源雲盤中異動 大幅上漲5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555008292","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555008292?lang=zh_tw&edition=fundamental","pubTime":"2025-07-31 13:05","pubTimestamp":1753938309,"startTime":"0","endTime":"0","summary":"2025年07月31日下午盘13时05分，明源云股票出现异动，股价急速拉升5.00%。截至发稿，该股报3.360港元/股，成交量1166.8万股，换手率0.60%，振幅6.87%。机构评级方面，在所有2家参与评级的机构中，100%的券商给予持有建议，无券商给予买入、卖出建议。明源云股票所在的应用软件行业中，整体涨幅为0.98%。其相关个股中，天润云、有赞、金蝶国际涨幅较大，振幅较大的相关个股有驴迹科技股权、天润云、升华兰德，振幅分别为40.00%、19.79%、13.85%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073113050994c55af7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073113050994c55af7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1618","BK1583","BK1589","BK1518","BK1109","BK1607","00909","BK1117"],"gpt_icon":0}],"pageSize":20,"totalPage":54,"pageCount":9,"totalSize":1074,"code":"91000000","status":"200"}]}}